Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.99+0.04 (+4.57%)
Close on Nov 20, 2026Market cap $13.20MP/E –Yield 0.00%
Tvardi Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2021 it was $23.03M.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $23.03M | – |
See a number that looks wrong?